Trial intelligence / Profile preview

Bupropion for Smoking Cessation in Postpartum Women

NCT00119210Phase 4Terminated

Sponsor
Massachusetts General Hospital
Start
Mar 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Bupropion SR with Placebo (2 arms). Primary endpoints: Proportion of women who are eligible for the study, Proportion of eligible women who enroll in the study and 1 more. Started Mar 2005; status: terminated.

02

Drugs

bupropion
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00119210.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00119210.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call